An Anti-CD28 Domain Antibody, Lulizumab, in Systemic Lupus Erythematosus: Results of a Phase II Study

被引：0
|
作者：
Merrill, Joan T. [1 ]
Shevell, Diane E. [2 ]
Duchesne, Dominique [2 ]
Nowak, Miroslawa [2 ]
Kundu, Sudeep [2 ]
Girgis, Ihab G. [2 ]
Hu, Yanhua Sarah [2 ]
Nadler, Steven G. [3 ]
Banerjee, Subhashis [2 ]
Throup, John [2 ]
机构：
[1] Oklahoma Med Res Fdn, Arthrit & Clin Immunol, 825 NE 13th St, Oklahoma City, OK 73104 USA
[2] Bristol Myers Squibb, Princeton, NJ USA
[3] Bristol Myers Squibb, Immunosci Translat Res, Princeton, NJ USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
REVISED CRITERIA; CLASSIFICATION;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
972
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Endometriosis and the risks of systemic lupus erythematosus and rheumatoid arthritis in the Nurses' Health Study II
    Harris, Holly R.
    Costenbader, Karen H.
    Mu, Fan
    Kvaskoff, Marina
    Malspeis, Susan
    Karlson, Elizabeth W.
    Missmer, Stacey A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (07) : 1279 - 1284
  • [22] Anti-Smith antibody is associated with disease activity in patients with new-onset systemic lupus erythematosus
    Ahn, Sung Soo
    Jung, Seung Min
    Yoo, Juyoung
    Lee, Sang-Won
    Song, Jason Jungsik
    Park, Yong-Beom
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (11) : 1937 - 1944
  • [23] Performance Characteristics of Different Anti-Double-Stranded DNA Antibody Assays in the Monitoring of Systemic Lupus Erythematosus
    Mahler, Michael
    Bentow, Chelsea
    O'Malley, Tyler
    Ibarra, Claudia
    Conklin, John
    Aure, Mary Ann R.
    Dervieux, Thierry
    JOURNAL OF IMMUNOLOGY RESEARCH, 2017, 2017
  • [24] Cutaneous vasculitis in systemic lupus erythematosus: association with anti-ribosomal P protein antibody and Raynaud phenomenon
    Shinjo, Samuel Katsuyuki
    Bonfa, Eloisa
    CLINICAL RHEUMATOLOGY, 2011, 30 (02) : 173 - 177
  • [25] Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus
    Ishizaki, Jun
    Saito, Kazuyoshi
    Nawata, Masao
    Mizuno, Yasushi
    Tokunaga, Mikiko
    Sawamukai, Norifumi
    Tamura, Masahito
    Hirata, Shintaro
    Yamaoka, Kunihiro
    Hasegawa, Hitoshi
    Tanaka, Yoshiya
    RHEUMATOLOGY, 2015, 54 (03) : 405 - 412
  • [26] Effects of CD134 monoclonal antibody on hemolysis activities and expression of perforin in peripheral blood mononuclear cells of systemic lupus erythematosus patients
    Li, Ming
    Yang, Qingrui
    Zhang, Yuanchao
    HYBRIDOMA, 2007, 26 (04): : 191 - 199
  • [27] Belimumab safety in adult and paediatric Chinese patients with systemic lupus erythematosus: A Phase 4, multicentre, observational study
    Zhang, Zhuoli
    Ye, Zhizhong
    He, Shanzhi
    Tang, Lin
    Xie, Chuanmei
    Yin, Songlou
    Chi, Shuhong
    Yang, Jing
    Yu, Qinghong
    Yang, Min
    Zhao, Xuefeng
    He, Yifan
    Hu, Jingwen
    Wang, Weibo
    Tung, Annie
    LUPUS, 2024, 33 (14) : 1562 - 1572
  • [28] CD40 and CD72 expression and prognostic values among children with systemic lupus erythematosus: a case-control study
    Asmiyou, Abtisam
    Bakr, Ashraf M.
    Shahin, Doaa A.
    Wahba, Yahya
    LUPUS, 2020, 29 (10) : 1270 - 1276
  • [29] CD4+CD25highFOXP3+ T regulatory cells as a biomarker of disease activity in systemic lupus erythematosus: a prospective study
    Tselios, K.
    Sarantopoulos, A.
    Gkougkourelas, I.
    Boura, P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : 630 - 639
  • [30] Prognostic implications of active discoid lupus erythematosus and malar rash at the time of diagnosis of systemic lupus erythematosus: Results from a prospective cohort study
    Drucker, A. M.
    Su, J.
    Mussani, F.
    Siddha, S. K.
    Gladman, D. D.
    Urowitz, M. B.
    LUPUS, 2016, 25 (04) : 376 - 381
12345